Skip to content

Online Quality of Life Monitoring for the optimization of care programs for cardiac disease in children and adolescents

Online Quality of Life Monitoring for the optimization of care programs for cardiac disease in children and adolescents - LQM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016358
Enrollment
520
Registered
2019-02-22
Start date
2019-06-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral abnormalities and Quality of Life within congenital cardiac defects

Interventions

Group 1: Intervention group: monitoring using standardized computer-based screening questionnaires for patients (school age or above) or their parents
forwarding abnormal results to the treating physician (pediatrician, general practitioner) in order to induce prompt subject-specific clarification (QoLM) Group 2: Control group: Treatment-as-usual (T
without access to the results (doctor & patient)

Sponsors

Universitätsklinikum Ulm, Kinder- und Jugendpsychiatrie/ Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children between the ages of 0-17 years; diagnosis of a congenital heart diseases; appointment for regular ambulant treatment in a participating clinical institution; informed consent of the legal guardian concerning the participation of the study; informed assent of the children/adolescents (as far as possible regarding the developmental status); sufficient German, English, or Turkish language skills of the patient (8 years or above) and/or the adult companion in order to comprehend the content of the questionnaires and the interview.

Exclusion criteria

Exclusion criteria: Emergency treatments (urgent, superior medical acute interventions which (initially) prevent the realization of the screening interview); patients with a known intellectual disability and/or a syndromal development disorder (e.g. trisomy 21); privately insured patients

Design outcomes

Primary

MeasureTime frame
Improvement of the early detection of the need for rehabilitation within patients with congenital heart disease

Secondary

MeasureTime frame
Feasibility in clinical daily routine, participants satisfaction, health-related quality of life, reduction of behavioral abnormalities

Countries

Germany

Contacts

Public ContactMandy Niemitz

Universitätsklinikum Ulm Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie

mandy.niemitz@uniklinik-ulm.de0731 500-62660

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026